Product Details:
| Strength | 250 mg |
| Brand | Geftinat |
| Packaging Size | 30 tablets |
| Composition | Gefitinib |
| Treatment Type | NSCLC |
| Manufacturer | Natco |
Product Details:
| Strength | 250 mg |
| Brand | Gefticip |
| Packaging Size | 30 tablets |
| Composition | Gefitinib |
| Treatment Type | NSCLC |
| Manufacturer | Cipla |
Gefticip 250mg tablet (Gefitinib) is an oral, targeted cancer medication used to treat locally advanced or metastatic Non-Small Cell Lung Cancer (NSCLC) in patients with specific EGFR gene mutations. It inhibits EGFR tyrosine kinase, slowing tumor growth. It is usually taken once daily, with or without food